These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15082669)

  • 1. Genital dysplasia in women infected with human immunodeficiency virus.
    Taylor G; Wolff T; Khanna N; Furth P; Langenberg P
    J Am Board Fam Pract; 2004; 17(2):108-13. PubMed ID: 15082669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of highly active antiretroviral therapy on human papillomavirus clearance and cervical cytology.
    Paramsothy P; Jamieson DJ; Heilig CM; Schuman PC; Klein RS; Shah KV; Rompalo AM; Cu-Uvin S; Duerr A
    Obstet Gynecol; 2009 Jan; 113(1):26-31. PubMed ID: 19104356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of highly active antiretroviral therapy in human papillomavirus-induced genital dysplasia in HIV-1-infected patients.
    Orlando G; Fasolo MM; Schiavini M; Signori R; Cargnel A
    AIDS; 1999 Feb; 13(3):424-5. PubMed ID: 10199237
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of highly active antiretroviral therapy (HAART) and menopause on risk of progression of cervical dysplasia in human immune-deficiency virus- (HIV-) infected women.
    Kim SC; Messing S; Shah K; Luque AE
    Infect Dis Obstet Gynecol; 2013; 2013():784718. PubMed ID: 24453469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women.
    Ahdieh-Grant L; Li R; Levine AM; Massad LS; Strickler HD; Minkoff H; Moxley M; Palefsky J; Sacks H; Burk RD; Gange SJ
    J Natl Cancer Inst; 2004 Jul; 96(14):1070-6. PubMed ID: 15265968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical dysplasia in HIV-seropositive women: role of human papillomavirus infection and immune status.
    Garzetti GG; Ciavattini A; Butini L; Vecchi A; Montroni M
    Gynecol Obstet Invest; 1995; 40(1):52-6. PubMed ID: 7557645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between highly active antiretroviral therapy and the presence of HPV, premalignant and malignant cervical lesions in sub-Saharan Africa, a systematic review: current evidence and directions for future research.
    Menon S; Rossi R; Zdraveska N; Kariisa M; Acharya SD; Vanden Broeck D; Callens S
    BMJ Open; 2017 Aug; 7(8):e015123. PubMed ID: 28780541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical dysplasia in women infected with the human immunodeficiency virus (HIV): a correlation with HIV viral load and CD4+ count.
    Davis AT; Chakraborty H; Flowers L; Mosunjac MB
    Gynecol Oncol; 2001 Mar; 80(3):350-4. PubMed ID: 11263930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy.
    Lillo FB; Ferrari D; Veglia F; Origoni M; Grasso MA; Lodini S; Mastrorilli E; Taccagni G; Lazzarin A; Uberti-Foppa C
    J Infect Dis; 2001 Sep; 184(5):547-51. PubMed ID: 11494160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men.
    Palefsky JM; Holly EA; Efirdc JT; Da Costa M; Jay N; Berry JM; Darragh TM
    AIDS; 2005 Sep; 19(13):1407-14. PubMed ID: 16103772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased regression and decreased incidence of human papillomavirus-related cervical lesions among HIV-infected women on HAART.
    Adler DH; Kakinami L; Modisenyane T; Tshabangu N; Mohapi L; De Bruyn G; Martinson NA; Omar T
    AIDS; 2012 Aug; 26(13):1645-52. PubMed ID: 22555167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markers of human papillomavirus infection and their correlation with cervical dysplasia in human immunodeficiency virus-positive women.
    Riva E; Serraino D; Pierangeli A; Bambacioni F; Zaniratti S; Minosse C; Selleri M; Bucci M; Scagnolari C; Degener AM; Capobianchi MR; Antonelli G; Dianzani F;
    Clin Microbiol Infect; 2007 Jan; 13(1):94-7. PubMed ID: 17184295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical dysplasia in Nigerian women infected with HIV.
    Agaba PA; Thacher TD; Ekwempu CC; Idoko JA
    Int J Gynaecol Obstet; 2009 Nov; 107(2):99-102. PubMed ID: 19619874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune response in cervical dysplasia induced by human papillomavirus: the influence of human immunodeficiency virus-1 co-infection -- review.
    Nicol AF; Fernandes AT; Bonecini-Almeida Mda G
    Mem Inst Oswaldo Cruz; 2005 Feb; 100(1):1-12. PubMed ID: 15867955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of cervical cytologic changes among HIV-infected women with normal cytology in the HAART era.
    Sirera G; Videla S; López-Blázquez R; Llatjos M; Tarrats A; Castellà E; Grane N; Alcalde C; Tural C; Rey-Joly C; Clotet B
    AIDS Res Hum Retroviruses; 2007 Aug; 23(8):965-71. PubMed ID: 17725412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy.
    Hung CC; Chen MY; Hsiao CF; Hsieh SM; Sheng WH; Chang SC
    AIDS; 2003 Dec; 17(18):2615-22. PubMed ID: 14685055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women's HIV Study Group.
    Hankins C; Coutlée F; Lapointe N; Simard P; Tran T; Samson J; Hum L
    CMAJ; 1999 Jan; 160(2):185-91. PubMed ID: 9951439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy.
    Salmon-Céron D; Mazeron MC; Chaput S; Boukli N; Senechal B; Houhou N; Katlama C; Matheron S; Fillet AM; Gozlan J; Leport C; Jeantils V; Freymuth F; Costagliola D
    AIDS; 2000 May; 14(8):1041-9. PubMed ID: 10853987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High recurrence rate of cervical dysplasia and persistence of HPV infection in HIV-1-infected women.
    Gingelmaier A; Grubert T; Kaestner R; Mylonas I; Weissenbacher T; Bergauer F; Barthell L; Friese K
    Anticancer Res; 2007; 27(4A):1795-8. PubMed ID: 17649775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
    Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
    Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.